Anna Berg

1.1k citations

21 papers · 683 indexed · h-index 16

Impact in

Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments
Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment

Papers in ⓘ

Obstetrics and Gynecology 10
- Endometrial and Cervical Cancer Treatments 10
- Uterine Myomas and Treatments 3
Molecular Biology 9
- Angiogenesis and VEGF in Cancer 2

Co-authors: Camilla Krakstad (17 shared papers)Jone Trovik (17 shared papers)Helga B. Salvesen (16 shared papers)Ingvild L. Tangen (12 shared papers)Mari K. Halle (12 shared papers)Henrica M.J. Werner (14 shared papers)Margrét Árnadóttir (2 shared papers)Erling A. Høivik (13 shared papers)
Journals: Oncotarget (9 papers)Gynecologic Oncology (2 papers)Clinical Cancer Research (1 paper)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)British Journal of Cancer (1 paper)
Partner nations: Norway United States Thailand

In The Last Decade

Anna Berg

21 papers receiving 676 citations

Peers

Countries citing papers authored by Anna Berg

Since Specialization

Citations

This map shows the geographic impact of Anna Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Berg more than expected).

Fields of papers citing papers by Anna Berg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Berg. The network helps show where Anna Berg may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Berg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Berg Line = papers co-authored together Anna Berg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy Kidney International ·Anna Berg, Peter Nilsson‐Ehle, Margrét Árnadóttir	1999	71
2	ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas Modern Pathology ·Henrica M.J. Werner, Anna Berg, Elisabeth Wik, Even Birkeland, Camilla Krakstad, Kanthida Kusonmano, Kjell Petersen, Karl H. Kalland, Anne M. Øyan, Lars A. Akslen, Jone Trovik, Helga B. Salvesen	2012	62
3	Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions European Journal of Cancer ·Ingvild L. Tangen, Henrica M.J. Werner, Anna Berg, Mari K. Halle, Kanthida Kusonmano, Jone Trovik, Erling A. Høivik, Gordon B. Mills, Camilla Krakstad, Helga B. Salvesen	2014	61
4	HER2 expression patterns in paired primary and metastatic endometrial cancer lesions British Journal of Cancer ·Mari K. Halle, Ingvild L. Tangen, Hege F. Berg, Erling A. Høivik, Karen K. Mauland, Kanthida Kusonmano, Anna Berg, Antoni Hurtado, Karl‐Henning Kalland, Anne M. Øyan, Ingunn M. Stefansson, Olav Karsten Vintermyr, Henrica M.J. Werner, Ingfrid S. Haldorsen, Jone Trovik, Helga B. Salvesen, Camilla Krakstad	2017	57
5	Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC SHILAP Revista de lepidopterología ·Gro Vatne Røsland, Sissel E. Dyrstad, Deusdedit Tusubira, Reham Helwa, Tuan Zea Tan, Maria L. Lotsberg, Ina K. N. Pettersen, Anna Berg, Charlotte K. Kindt, Fredrik Hoel, Kirstine Jacobsen, Ari Jón Arason, Agnete S. T. Engelsen, Henrik J. Ditzel, Per Eystein Lønning, Camilla Krakstad, Jean Paul Thiery, James B. Lorens, Stian Knappskog, Karl Johan Tronstad	2019	56
6	Androgen receptor as potential therapeutic target in metastatic endometrial cancer Oncotarget ·Ingvild L. Tangen, Therese Bredholt Onyango, Reidun Kopperud, Anna Berg, Mari K. Halle, Anne M. Øyan, Henrica M.J. Werner, Jone Trovik, Karl‐Henning Kalland, Helga B. Salvesen, Camilla Krakstad	2016	56
7	Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients Oncotarget ·Anna Berg, Erling A. Høivik, Siv Mjøs, Frederik Holst, Henrica M.J. Werner, Ingvild L. Tangen, Amaro Taylor‐Weiner, William J. Gibson, Kanthida Kusonmano, Elisabeth Wik, Jone Trovik, Mari K. Halle, Anne M. Øyan, Karl-Henning Kalland, Andrew D. Cherniack, Rameen Beroukhim, Ingunn M. Stefansson, Gordon B. Mills, Camilla Krakstad, Helga B. Salvesen	2014	40
8	ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma Oncotarget ·Camilla Krakstad, Ingvild L. Tangen, Erling A. Høivik, Mari K. Halle, Anna Berg, Henrica M.J. Werner, Maria B. Ræder, Kanthida Kusonmano, June X. Zou, Anne M. Øyan, Ingunn M. Stefansson, Jone Trovik, Karl‐Henning Kalland, Hong-Wu Chen, Helga B. Salvesen	2015	38
9	High visceral fat percentage is associated with poor outcome in endometrial cancer Oncotarget ·Karen K. Mauland, Øyvin Eng, Sigmund Ytre‐Hauge, Ingvild L. Tangen, Anna Berg, Helga B. Salvesen, Øyvind Salvesen, Camilla Krakstad, Jone Trovik, Erling A. Høivik, Henrica M.J. Werner, Gunnar Mellgren, Ingfrid S. Haldorsen	2017	37
10	Dub3 controls DNA damage signalling by direct deubiquitination of H2AX Molecular Oncology ·Maria Rocio Delgado‐Diaz, Yusé Martín, Anna Berg, Raimundo Freire, Veronique A. J. Smits	2014	35
11	Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer Oncotarget ·Anna Berg, Kristine E. Fasmer, Karen K. Mauland, Sigmund Ytre‐Hauge, Erling A. Høivik, J. Husby, Ingvild L. Tangen, Jone Trovik, Mari K. Halle, Kathrine Woie, Line Bjørge, Atle Bjørnerud, Helga B. Salvesen, Henrica M.J. Werner, Camilla Krakstad, Ingfrid S. Haldorsen	2016	31
12	Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene Oncotarget ·Erling A. Høivik, Kanthida Kusonmano, Mari K. Halle, Anna Berg, Elisabeth Wik, Henrica M.J. Werner, Kjell Petersen, Anne M. Øyan, Karl‐Henning Kalland, Camilla Krakstad, Jone Trovik, Martin Widschwendter, Helga B. Salvesen	2014	29
13	PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer Scientific Reports ·Siv Mjøs, Henrica M.J. Werner, Even Birkeland, Frederik Holst, Anna Berg, Mari K. Halle, Ingvild L. Tangen, Kanthida Kusonmano, Karen K. Mauland, Anne M. Øyan, Karl‐Henning Kalland, Aurélia E. Lewis, Gordon B. Mills, Camilla Krakstad, Jone Trovik, Helga B. Salvesen, Erling A. Høivik	2017	23
14	PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma Clinical Cancer Research ·Frederik Holst, Henrica M.J. Werner, Siv Mjøs, Erling A. Høivik, Kanthida Kusonmano, Elisabeth Wik, Anna Berg, Even Birkeland, William J. Gibson, Mari K. Halle, Jone Trovik, Andrew D. Cherniack, Karl-Henning Kalland, Gordon B. Mills, Christian F. Singer, Camilla Krakstad, Rameen Beroukhim, Helga B. Salvesen	2018	21
15	Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas Gynecologic Oncology ·Ingfrid S. Haldorsen, Anna Berg, Henrica M.J. Werner, Inger J. Magnussen, Harald Helland, Øyvind Salvesen, Jone Trovik, Helga B. Salvesen	2012	17
16	Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions Gynecologic Oncology ·Tina Fonnes, Hege F. Berg, Therese Bredholt, Per‐Henrik Edqvist, Kristina Sortland, Anna Berg, Helga B. Salvesen, Lars A. Akslen, Henrica M.J. Werner, Jone Trovik, Ingvild L. Tangen, Camilla Krakstad	2017	16
17	The effects of adrenocorticotrophic hormone and cortisol on homocysteine and vitamin B concentrations Clinical Chemistry and Laboratory Medicine (CCLM) ·Anna Berg, Arnar Rafnsson, Magnús Jóhannsson, Björn Hultberg, Margrét Árnadóttir	2006	9
18	Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer PLoS ONE ·Kanthida Kusonmano, Mari K. Halle, Elisabeth Wik, Erling A. Høivik, Camilla Krakstad, Karen K. Mauland, Ingvild L. Tangen, Anna Berg, Henrica M.J. Werner, Jone Trovik, Anne M. Øyan, Karl‐Henning Kalland, Inge Jonassen, Helga B. Salvesen, Kjell Petersen	2018	9
19	Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients Oncotarget ·Karen K. Mauland, Zhenlin Ju, Ingvild L. Tangen, Anna Berg, Karl-Henning Kalland, Anne M. Øyan, Line Bjørge, Shannon N. Westin, Camilla Krakstad, Jone Trovik, Gordon B. Mills, Erling A. Høivik, Henrica M.J. Werner	2017	8
20	Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers Oncotarget ·Anna Berg, Ankush Gulati, Sigmund Ytre‐Hauge, Kristine E. Fasmer, Karen K. Mauland, Erling A. Høivik, J. Husby, Ingvild L. Tangen, Jone Trovik, Mari K. Halle, Ingunn M. Stefansson, Lars A. Akslen, Kathrine Woie, Line Bjørge, Helga B. Salvesen, Øyvind Salvesen, Henrica M.J. Werner, Ingfrid S. Haldorsen, Camilla Krakstad	2017	4

About Anna Berg

Anna Berg is a scholar working on Obstetrics and Gynecology, Molecular Biology, Reproductive Medicine, Cancer Research and Oncology, having authored 21 papers that have together received 683 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (10 papers), Ovarian cancer diagnosis and treatment (7 papers), Cancer Genomics and Diagnostics (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Uterine Myomas and Treatments (3 papers), Cancer, Lipids, and Metabolism (2 papers), Endometriosis Research and Treatment (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Obstetrics and Gynecology (256 citations), Reproductive Medicine (184 citations), Cancer Research (150 citations), Nephrology (58 citations) and Oncology (167 citations). Anna Berg has collaborated with scholars based in Norway, United States and Thailand. Frequent co-authors include Camilla Krakstad, Jone Trovik, Helga B. Salvesen, Ingvild L. Tangen, Mari K. Halle, Henrica M.J. Werner, Margrét Árnadóttir, Erling A. Høivik, Kanthida Kusonmano and Peter Nilsson‐Ehle. Their work appears in journals such as Oncotarget, Gynecologic Oncology, Clinical Cancer Research, Clinical Chemistry and Laboratory Medicine (CCLM) and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact